A recent study from Columbia University has raised important questions about the medications used to treat high blood ...

Dimerix has achieved a key milestone in its ACTION3 phase III trial of lead asset DMX-200 into focal segmental ...

New Delhi, Jan 10 Beta blockers are not commonly known to lower potassium levels, and are a well-tolerated drug, said experts on Friday, expressing concerns on government body’s alert on these ...

"Beta-blockers for non-essential conditions such as high blood pressure should not be used as a first line drug," Dr Gupta said. He added that the IPC alert was issued only as an advisory and ...

Smithers opened an office in Martinsville and “prescribed controlled substances to every patient in his practice,” distributing over 500,000 Schedule II drugs, including oxymorphone ...

placebo-controlled study of the efficacy and safety of DMX-200 in patients with FSGS who are receiving a stable dose of an angiotensin II receptor blocker (ARB). Planned blinded interim data ...

It has been assumed that the actions of the renin-angiotensin system in the brain and periphery arise from the interaction of Ang II with its receptors ... with vehicle (n=36), the AT 1 receptor ...

Clinical Benefits of ARB Therapy in the Treatment of Heart Failure Given the known benefits of ACE inhibitor therapy, any trial evaluating the effect of ARBs on mortality in heart failure needs to ...

Abstract We investigated the effects of angiotensin ... feedback Ang II receptor in hypertensive patients produces modest increases of plasma renin activity and Ang II that do not appear to affect the ...

Led by Paul Mescal, Gladiator II follows Lucius, who is forced to enter the infamous Colosseum after his home is conquered by the emperors who now lead Rome. Mescal is joined by an all-star ...

The probability of event-free survival in patients receiving valsartan 160 mg b.i.d. vs. placebo in addition to optimal medical therapy in patients with systolic heart failure (Kaplan-Meier ...

This phase III trial is a randomised, double-blind, placebo-controlled study of the efficacy and safety of DMX200 in patients with FSGS who are receiving a stable dose of an angiotensin II receptor ...